Market Cap 251.67B
Revenue (ttm) 104.18B
Net Income (ttm) 12.36B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 18.09
Profit Margin 11.87%
Debt to Equity Ratio 2.26
Volume 322,700
Avg Vol 431,706
Day's Range N/A - N/A
Shares Out 2.58B
Stochastic %K 10%
Beta 0.53
Analysts Sell
Price Target $109.33

Company Profile

Nestlé S.A., together with its subsidiaries, operates as a food and beverage company. It operates through Zone North America; Zone Europe; Zone Asia, Oceania and Africa; Zone Latin America; Zone Greater China; Nestlé Health Science; and Nespresso segments. The company offers water under the Acqua Panna, Nestlé Pure Life, Perrier, S.Pellegrino, Sanpellegrino, and other local brands; and chocolate and confectionery products under the Aero, Baci Perugina, KitKat, Milkybar, Smarties, and other local...

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 41 21 924 1111
Address:
Avenue Nestlé 55, Vevey, Switzerland
ArsenalFC23
ArsenalFC23 Dec. 3 at 7:08 PM
$UPS Still holding my 86.50 AVG 💪🏻 Not selling below 110. Currently also holding $TGT $PYPL $NSRGY
0 · Reply
mikesterz7
mikesterz7 Dec. 2 at 2:05 PM
$NSRGY Freshly appointed CEO Philipp Navratil is undertaking a cost-reduction revamp of the food giant.
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 2 at 1:46 PM
Wake Up And Smell The Coffee! Big Food Is Rethinking Its Caffeine Bets As Trump Tariffs Brew Trouble For The Market $NSRGY $KO $KDP https://stocktwits.com/news/equity/markets/wakeup-smell-the-coffee-big-food-is-rethinking-its-caffeine-bets-as-trump-tariffs-brew-trouble/cLIaljKRE0z
0 · Reply
Lizardbronsen
Lizardbronsen Nov. 23 at 5:23 PM
0 · Reply
randy212
randy212 Nov. 23 at 4:53 PM
$BYND $NSRGY why buy a company they already beaten and facing bankruptcy?
1 · Reply
bladerunner45
bladerunner45 Nov. 23 at 4:49 PM
$BYND 🚨🚨🚨🚨🚨 Back in 2019, BEYOND MEAT was Nestle competitor. Now Nestle is in the perfect position to buy out BEYOND MEAT $NSRGY 🚨🚨🚨🚨🚨 https://www.deraktionaer.de/artikel/aktien/nestl-macht-jagd-auf-beyond-meat-doch-wie-viel-potenzial-hat-die-aktie-noch-20190654.html
1 · Reply
Okadarlan
Okadarlan Nov. 9 at 10:01 AM
$NSRGY hope u all followed this one.
0 · Reply
bulld0zer40k
bulld0zer40k Nov. 9 at 6:45 AM
$CELH I have the same experience holding $AIMT years ago before $NSRGY bought them. The stock price was significantly depressed by hedge funds to help with the acquisition. I believe PepsiCo is doing the same thing to save their growth problem. They are trying to convince the shareholders that Celsius is failing in execution and it’s wise to sell for <$100 BO.
0 · Reply
SenefAS
SenefAS Nov. 4 at 12:00 PM
Seres Therapeutics advanced earnings on the 5 November… Jurisdiction vs Vedanta are on the 6 November with Nestle hand in hand represented by the same lawyers… What’s the next move ? Buyout or partnership on the 7 November ? $MCRB $NSRGY $VEDL $XBI #biotech
2 · Reply
SenefAS
SenefAS Nov. 4 at 11:50 AM
$MCRB Nice find @Thepark88 This is the reason why the VOWST sales are confidential… Same lawyers representing Seres & Nestle hand in hand $NSRGY When buyout ?
0 · Reply
Latest News on NSRGY
No data available.
ArsenalFC23
ArsenalFC23 Dec. 3 at 7:08 PM
$UPS Still holding my 86.50 AVG 💪🏻 Not selling below 110. Currently also holding $TGT $PYPL $NSRGY
0 · Reply
mikesterz7
mikesterz7 Dec. 2 at 2:05 PM
$NSRGY Freshly appointed CEO Philipp Navratil is undertaking a cost-reduction revamp of the food giant.
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 2 at 1:46 PM
Wake Up And Smell The Coffee! Big Food Is Rethinking Its Caffeine Bets As Trump Tariffs Brew Trouble For The Market $NSRGY $KO $KDP https://stocktwits.com/news/equity/markets/wakeup-smell-the-coffee-big-food-is-rethinking-its-caffeine-bets-as-trump-tariffs-brew-trouble/cLIaljKRE0z
0 · Reply
Lizardbronsen
Lizardbronsen Nov. 23 at 5:23 PM
0 · Reply
randy212
randy212 Nov. 23 at 4:53 PM
$BYND $NSRGY why buy a company they already beaten and facing bankruptcy?
1 · Reply
bladerunner45
bladerunner45 Nov. 23 at 4:49 PM
$BYND 🚨🚨🚨🚨🚨 Back in 2019, BEYOND MEAT was Nestle competitor. Now Nestle is in the perfect position to buy out BEYOND MEAT $NSRGY 🚨🚨🚨🚨🚨 https://www.deraktionaer.de/artikel/aktien/nestl-macht-jagd-auf-beyond-meat-doch-wie-viel-potenzial-hat-die-aktie-noch-20190654.html
1 · Reply
Okadarlan
Okadarlan Nov. 9 at 10:01 AM
$NSRGY hope u all followed this one.
0 · Reply
bulld0zer40k
bulld0zer40k Nov. 9 at 6:45 AM
$CELH I have the same experience holding $AIMT years ago before $NSRGY bought them. The stock price was significantly depressed by hedge funds to help with the acquisition. I believe PepsiCo is doing the same thing to save their growth problem. They are trying to convince the shareholders that Celsius is failing in execution and it’s wise to sell for <$100 BO.
0 · Reply
SenefAS
SenefAS Nov. 4 at 12:00 PM
Seres Therapeutics advanced earnings on the 5 November… Jurisdiction vs Vedanta are on the 6 November with Nestle hand in hand represented by the same lawyers… What’s the next move ? Buyout or partnership on the 7 November ? $MCRB $NSRGY $VEDL $XBI #biotech
2 · Reply
SenefAS
SenefAS Nov. 4 at 11:50 AM
$MCRB Nice find @Thepark88 This is the reason why the VOWST sales are confidential… Same lawyers representing Seres & Nestle hand in hand $NSRGY When buyout ?
0 · Reply
SenefAS
SenefAS Oct. 30 at 2:41 PM
$MCRB You're not going to advance the earnings for the business update if you don't have any solutions... In my opinion, the next few days are crucial. $NSRGY
0 · Reply
BigBullyHauling
BigBullyHauling Oct. 29 at 5:29 PM
$BYND it was pre pandemic and before BYND flew to its crazy price but $NSRGY had target a partnership or MA. Now at today’s price and debt consolidation is the target back in sights? 🧐
0 · Reply
abubnic
abubnic Oct. 28 at 6:12 PM
$HSY $NSRGY $MDLZ ​October 28th is National Chocolate Day. You know what to do!
0 · Reply
Hastamatr
Hastamatr Oct. 22 at 3:16 AM
$OTLY And connecting the dots , with my previous post about Goudet. JDE Peets ($JDEPY) merging with Keurig ($KDP) and beverages will be spinned off. From JAB website : “JAB works with three globally recognized Senior Advisors who provide advice on investments and various governance and strategy matters: Bertrand Badré, Olivier Goudet, and Antonio Weiss.“ Oatly investment (10% of the company) of Goudet through Platin SARL must be personal but JAB-aligned signal of strategic interest in especially within the coffee ecosystem that JAB is now re-consolidating via the Keurig / JDE Peet’s combination… So it will not be Nestle($NSRGY ) that I was always thinking about… It will be one of the JAB future companies to take it over in 2027/2028 after merger&spin off finalizes. And first stone laid… Don’t get surprised if he increases his position gradually… Wow, now all makes much better sense … Prepare for the ride guys…🤩
2 · Reply
MisterSplashyPants
MisterSplashyPants Oct. 16 at 9:33 PM
$NSRGY Analysts ratings: 11 Buys, 12 Holds, and 1 Sell with an average 12-month PT of 85 CHF (Swiss Franc)
0 · Reply
Okadarlan
Okadarlan Oct. 16 at 3:50 PM
$NSRGY lets gooo
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 16 at 2:23 PM
Nestle’s US-listed Shares Rally On Plans To Reduce 16,000 Global Jobs Over Two Years $NSRGY https://stocktwits.com/news/equity/markets/nestles-us-listed-shares-rally-on-plans-to-reduce-16-000-global-jobs/ch6p3LSR3np
0 · Reply
inspector_gadget86
inspector_gadget86 Oct. 16 at 8:07 AM
$NSRGY In a bid to improve operational efficiency, the firm said it will cut 12,000 white-collar jobs and a further 4,000 roles will be reduced over the next two years.
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 16 at 7:10 AM
Nestle To Cut Nearly 6% Roles To Save Costs: Retail Mood Bearish $NSRGY $XLP https://stocktwits.com/news/equity/markets/nestle-to-cut-nearly-6-roles-to-save-costs-retail-mood-bearish/ch6YHwlR3Vp
0 · Reply
Numbersandfacts
Numbersandfacts Sep. 29 at 3:39 PM
$MCRB Danone, one of Nestle $NSRGY rivals and competitors, has acquired the akkermansia company. They understand the microbiome is the future of food, medicines and supplements. If Nestle doesn't want Seres its patents and pipeline, I say the admin should reach out to Danone!
0 · Reply
SenefAS
SenefAS Sep. 24 at 11:31 AM
Canaccord raised the price target on Seres Therapeutics to $22 from $14 and keeps a Buy rating on the shares. The firm noted the FDA provided feedback on Seres’ proposed Phase 2 SER-155 study in bloodstream infections, which could aid in partnership discussions $MCRB $XBI $NSRGY
0 · Reply
Numbersandfacts
Numbersandfacts Sep. 18 at 3:20 PM
$MCRB Danone has bought the Akkermansia company. $NSRGY your move!
0 · Reply